Kinjal Shah (Former)
1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
(
- Contribution to journal › Article
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article
- 2022
-
Mark
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
(
- Contribution to journal › Scientific review
- 2021
-
Mark
The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia
(
- Contribution to journal › Article
-
Mark
Mechanisms of therapy resistance in acute lymphoblastic leukemia
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
T cell receptor (TCR) signaling in health and disease
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
(
- Contribution to journal › Article
-
Mark
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
(
- Contribution to journal › Letter
- 2018
-
Mark
Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
(
- Contribution to journal › Letter
- 2017
-
Mark
Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Article